Abstract: A liquid ammonia phase-change cooling type hybrid power thermal management system. The system comprises an injector, a liquid ammonia hydrogen supply system, a liquid ammonia common rail pipe, a fuel oil common rail pipe and an oil tank, wherein the liquid ammonia hydrogen supply system comprises a liquid ammonia storage tank, an ammonia pumping system, a flow dividing system and an ammonia inlet and outlet system, the fuel oil common rail pipe is respectively connected with the oil tank and a one-way oil inlet of the injector, the liquid ammonia common rail pipe is respectively connected with the ammonia inlet and outlet system and a one-way ammonia inlet of the injector, an ammonia inlet pipe and an ammonia return pipe are arranged in the ammonia inlet and outlet system, the ammonia pumping system comprises a liquid ammonia storage flow divider, a low-pressure pump and a high-pressure pump.

Abstract: An image capturing method can be applied to an application, and include: determining a dimension adjustment approach set for a preset object in an acquired image to be processed after a dimension adjustment function of the application is turned on; and obtaining and displaying an adjusted image by adjusting a dimension of the preset object in the image to be processed according to the dimension adjustment approach, so as to support real-time preview of the adjusted image. As the dimension of the preset object in the image to be processed is adjusted in the image capturing process, the image capturing experience of the user is improved, and satisfying photos or videos can be obtained quickly.

Abstract: A method of controlling a camera is provided, the method being applicable to a terminal device, the terminal device including a Dynamic Vision Sensor (DVS) collecting circuit, and the method includes: obtaining event data collected by the DVS collecting circuit, while the terminal device performs photographing with a camera component in the terminal device; identifying an action of a designated face region of a control object within a collection range of the DVS collecting circuit according to the event data; and upon identification of a target action of the designated face region, controlling the camera component to perform a target operation corresponding to the target action.

Abstract: A camera module includes: a plurality of lenses; an image sensing component disposed on an imaging side of the plurality of lenses, and an area of a photosensitive region of the image sensing component is greater than an area of actual imaging region of a single lens and less than the sum of the area of actual imaging region of each of the lenses; and a plurality of optical switch components, disposed, between the plurality of lenses and the image sensing component, corresponding to the plurality of lenses, wherein the optical switch component is controlled to switch between an on state and an off state, and neighboring optical switch components corresponding to neighboring lenses whose actual imaging regions overlap each other are not turned on at the same time.

Abstract: An image capturing method can be applied to an application, and include: determining a dimension adjustment approach set for a preset object in an acquired image to be processed after a dimension adjustment function of the application is turned on; and obtaining and displaying an adjusted image by adjusting a dimension of the preset object in the image to be processed according to the dimension adjustment approach, so as to support real-time preview of the adjusted image. As the dimension of the preset object in the image to be processed is adjusted in the image capturing process, the image capturing experience of the user is improved, and satisfying photos or videos can be obtained quickly.

Abstract: Disclosed are a nicotinic acid or isonicotinic acid compound and a use thereof. The compound is the compound shown in Formula I, or a pharmaceutically acceptable salt, ester or solvate thereof. Efficacy tests demonstrate that the nicotinic acid compound can inhibit botulinum toxin endopeptidase activity in vitro, and has a significant protective effect on mice poisoned with botulinum toxin. On this basis, the compound may be used to prepare a drug preventing and/or treating botulinum toxin exposure and/or poisoning.

Abstract: A camera module includes: a plurality of lenses; an image sensing component disposed on an imaging side of the plurality of lenses, and an area of a photosensitive region of the image sensing component is greater than an area of actual imaging region of a single lens and less than the sum of the area of actual imaging region of each of the lenses; and a plurality of optical switch components, disposed, between the plurality of lenses and the image sensing component, corresponding to the plurality of lenses, wherein the optical switch component is controlled to switch between an on state and an off state, and neighboring optical switch components corresponding to neighboring lenses whose actual imaging regions overlap each other are not turned on at the same time.

Abstract: An electronic device includes: a device body defining an accommodating space therein; a camera module arranged on the device body, and configured to be positioned to be a first orientation and a second orientation, the camera module being configured to be located at the accommodating space of the device body and have a first photographing range at the first orientation, and to have a second photographing range at the second orientation; and an adjusting module arranged on the device body, and configured to drive the camera module at the first orientation to move outwards from the accommodating space, to move at least a part of the camera module outside the device body, and further to allow the camera module to be inclined to the second orientation.

Abstract: A method of controlling a camera is provided, the method being applicable to a terminal device, the terminal device including a Dynamic Vision Sensor (DVS) collecting circuit, and the method includes: obtaining event data collected by the DVS collecting circuit, while the terminal device performs photographing with a camera component in the terminal device; identifying an action of a designated face region of a control object within a collection range of the DVS collecting circuit according to the event data; and upon identification of a target action of the designated face region, controlling the camera component to perform a target operation corresponding to the target action.

Abstract: An electronic device includes: a device body defining an accommodating space therein; a camera module arranged on the device body, and configured to be positioned to be a first orientation and a second orientation, the camera module being configured to be located at the accommodating space of the device body and have a first photographing range at the first orientation, and to have a second photographing range at the second orientation; and an adjusting module arranged on the device body, and configured to drive the camera module at the first orientation to move outwards from the accommodating space, to move at least a part of the camera module outside the device body, and further to allow the camera module to be inclined to the second orientation.

Abstract: Disclosed are a nicotinic acid or isonicotinic acid compound and a use thereof. The compound is the compound shown in Formula I, or a pharmaceutically acceptable salt, ester or solvate thereof. Efficacy tests demonstrate that the nicotinic acid compound can inhibit botulinum toxin endopeptidase activity in vitro, and has a significant protective effect on mice poisoned with botulinum toxin. On this basis, the compound may be used to prepare a drug preventing and/or treating botulinum toxin exposure and/or poisoning.

Abstract: The present invention discloses a class of mercaptonicotinic acid compound and preparation method and use thereof; the general structural formula of the compound is as shown in Formula I. Experiment demonstrates that the mercaptonicotinic acid compound could inhibit activity of botulinum toxin endopeptidase and tetanus toxin endopeptidase in vitro, which has a significant protective effect on botulinum toxin poisoning in mice, and can be used for preparing medicine intended to prevent and/or treat botulism, as well as to prevent botulinum toxin exposure and tetanus.

Abstract: The present invention discloses a class of mercaptonicotinic acid compound and preparation method and use thereof; the general structural formula of the compound is as shown in Formula I. Experiment demonstrates that the mercaptonicotinic acid compound could inhibit activity of botulinum toxin endopeptidase and tetanus toxin endopeptidase in vitro, which has a significant protective effect on botulinum toxin poisoning in mice, and can be used for preparing medicine intended to prevent and/or treat botulism, as well as to prevent botulinum toxin exposure and tetanus.

Abstract: Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed in the processes are typically provided in a crystalline form.

Abstract: Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Abstract: Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Abstract: Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Abstract: Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed in the processes are typically provided in a crystalline form.

Abstract: Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions which are affected by SGLT inhibition.

Abstract: Provided are processes for the preparation of complexes that are useful in purifying compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The processes can reduce the number of steps needed to obtain the target compounds and the complexes formed in the processes are typically provided in a crystalline form.